Skip to main content

Portnoy David's Form 4 filing

Cryo Cell International Inc (CCEL) · filed Nov 10, 2022

Accession no.
0001209191-22-056434
Filed
Nov 10, 2022
Trade date
Nov 8-10, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 10 non-derivative transactions and 0 derivative transactions. Open-market purchases total $116.8K. Open-market sales total $102.4K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Portnoy DavidCIK 0001315416Director, Officer (Chairman, Co-CEO), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 8, 2022Common StockSSaleDisposed−5,000$5.05−$25,250855,742Direct
Nov 8, 2022Common StockSSaleDisposed−10,000$5.01−$50,100845,742Direct
Nov 10, 2022Common StockSSaleDisposed−4,000$4.91−$19,640841,742Direct
Nov 10, 2022Common StockSSaleDisposed−1,500$4.90−$7,350840,242Direct
Nov 10, 2022Common StockSSaleDisposed−5$5.00−$25840,237Direct
Nov 10, 2022Common StockJOtherDisposed−9,122$0.00$00Indirect
Nov 8, 2022Common StockPPurchaseAcquired+15,000$4.90+$73,500113,162Indirect
Nov 10, 2022Common StockPPurchaseAcquired+3,850$4.90+$18,865117,012Indirect
Nov 8, 2022Common StockPPurchaseAcquired+5,000$4.88+$24,400204,080Indirect
Nov 10, 2022Common StockJOtherDisposed−9,974$0.00$00Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)